Oregon Neurology Associates








CLINICAL TRIALS

Oregon Neurology Associates is excited to offer interested patients access to Clinical Trials in addition to standard treatments. Participating in a Clinical Trial is a unique opportunity to help further medical research and potentially receive new medications before they are available on the market. Our trials are typically in coordination with pharmaceutical companies and focus on providing access to new treatments or helping research existing therapies.

If you want to learn more about research at Oregon Neurology Associates or are interested in research participation, please give us a call at (541) 868-9430. If there is not an active trial for your diagnosis, there may be one coming soon.

ENROLLING TRIALS

Pediatric Epilepsy
Trial: A multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of lacosamide as adjunctive therapy in subjects with epilepsy ≥4 years to <17 years of age with partial-onset seizures.
Principal Investigator: Jeffrey Frank, MD
Sponsor: UCB
Click here for more information
https://clinicaltrials.gov/ct2/show/NCT01921205?term=sp0969&rank=1

Multiple Sclerosis
Trial: A placebo-controlled, randomized withdrawal evaluation of the efficacy and safety of baclofen ER capsules (GRS) in subjects with spasticity due to Multiple Sclerosis.
Principal Investigator: David Clark, MD
Sponsor: Sun Pharma
Click here for more information
https://clinicaltrials.gov/ct2/show/NCT01457352?term=sun+pharma&recr=Open&rank=2

Trial: Long-term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another approved disease-modifying therapy.
Principal Investigator: Mark Herring, MD
Sponsor: Novartis
Click here for more information
https://clinicaltrials.gov/ct2/show/NCT01442194?term=novartis+passage&rank=1








© Oregon Neurology Associates